RUBEN
NOGUEIRAS POZO
Investigador Oportunius
Tomas
Sobrino Moreiras
Publikationen, an denen er mitarbeitet Tomas Sobrino Moreiras (6)
2024
-
Correction to: Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial (Nature Communications, (2024), 15, 1, (5251), 10.1038/s41467-024-49121-3)
Nature Communications
-
Correction to: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe (Nature Communications, (2024), 15, 1, (3736), 10.1038/s41467-024-47751-1)
Nature Communications
-
dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe
Nature Communications, Vol. 15, Núm. 1
2021
-
Small extracellular vesicle-mediated targeting of hypothalamic AMPKα1 corrects obesity through BAT activation
Nature Metabolism, Vol. 3, Núm. 10, pp. 1415-1431
2019
-
Central nicotine induces browning through hypothalamic κ opioid receptor
Nature Communications, Vol. 10, Núm. 1
2017
-
Hypothalamic AMPK-ER Stress-JNK1 Axis Mediates the Central Actions of Thyroid Hormones on Energy Balance
Cell Metabolism, Vol. 26, Núm. 1, pp. 212-229.e12